Wendan Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wendan Cheng has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Chen Wang
Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China; Institute of Orthopaedics, Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
9 shared publicationsHaoran Yu
9 shared publications- Juehua Jing
Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, China
7 shared publications Xiao Ma
Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China; Institute of Orthopaedics, Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
6 shared publicationsChangming Wang
Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China; Institute of Orthopaedics, Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
5 shared publicationsHuihui Guo
Fuyang People’s Hospital, Fuyang, China
5 shared publications
Latest Publications
- Open Access
- 14 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (46) , e45684
A bibliometric analysis of artificial intelligence in medical education (2015–2025)
Background: The rapid development of artificial intelligence (AI) technology is profoundly reshaping the medical education model. However, to date, there has been no bibliometric study specifically focusing on AI and medical education. Methods: We retrieved 918 records from the Web of Science™ Core Collection. Using CiteSpace and VOSviewer, we conducted a scientometric analysis of these records, including temporal and spatial distribution, author distribution, references, journals, and keywords. Results: The analysis provides foundational information about this research domain, revealing a remarkable growth in scholarly interest over the past decade. Current research hotspots primarily focus on the application of large language models and virtual reality technologies in medical education. Conclusion: This study provides essential information for interested researchers. We hope this work will offer new perspectives for advancing the development of AI in medical education.
- 14 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (46) , e45684
Open AccessA bibliometric analysis of artificial intelligence in medical education (2015–2025)
Background: The rapid development of artificial intelligence (AI) technology is profoundly reshaping the medical education model. However, to date, there has been no bibliometric study specifically focusing on AI and medical education. Methods: We retrieved 918 records from the Web of Science™ Core Collection. Using CiteSpace and VOSviewer, we conducted a scientometric analysis of these records, including temporal and spatial distribution, author distribution, references, journals, and keywords. Results: The analysis provides foundational information about this research domain, revealing a remarkable growth in scholarly interest over the past decade. Current research hotspots primarily focus on the application of large language models and virtual reality technologies in medical education. Conclusion: This study provides essential information for interested researchers. We hope this work will offer new perspectives for advancing the development of AI in medical education.
- 25 September 2025
- Published by Elsevier in Tissue and Cell
- Vol. 98, 103157
MSC-derived exosomes promote chondrocyte proliferation and inhibit apoptosis by suppressing inflammation in osteoarthritis
- 25 September 2025
- Published by Elsevier in Tissue and Cell
- Vol. 98, 103157
MSC-derived exosomes promote chondrocyte proliferation and inhibit apoptosis by suppressing inflammation in osteoarthritis
- Open Access
- 4 June 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 555
The role of high knee range of motion at discharge on functional outcome after total knee arthroplasty: a retrospective cohort study
The study aimed to investigate the impact of high knee range of motion at discharge on functional outcome after total knee arthroplasty (TKA). We conducted a retrospective study of 136 patients with primary osteoarthritis who were treated between January 2022 and June 2023. Patients were classified according to the type of rehabilitation program: high range of motion (HROM) group or control group. In the HROM group, patients underwent high-intensity rehabilitation, especially without restricting the range of motion (ROM) following knee surgery. In the control group, patients received routine rehabilitation, with the affected knee achieving approximately 90 degrees of flexion at discharge. Patients' data related to postoperative knee ROM, Hospital for Special Surgery (HSS) score, visual analogue scale (VAS) score, transfusion rate, wound complications, thrombus of lower limb, and usage of analgesic drugs were recorded to assess the influence of ROM at discharge on clinical outcomes. The HROM group had a higher knee ROM compared to the control group at discharge (P < 0.001). There were no significant differences between the HROM group and the control group in the basic demographic information, hospital stay and operation time (P > 0.05). HSS scores and knee ROM in the HROM group were significantly higher than those in the control group 1 and 2 months after surgery (P < 0.001). There were no significant differences in VAS at 1, 2 and 7 days after surgery between the two groups. The usage of analgesic drugs, wound complications, thrombus of lower limb, and transfusion rates were similar between the two groups (P > 0.05). High knee ROM at discharge achieved through high-intensity rehabilitation is an effective and simple way to improve early knee mobility and function. The routine application of this protocol did not increase the incidence of wound complications.
- 4 June 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 555
Open AccessThe role of high knee range of motion at discharge on functional outcome after total knee arthroplasty: a retrospective cohort study
The study aimed to investigate the impact of high knee range of motion at discharge on functional outcome after total knee arthroplasty (TKA). We conducted a retrospective study of 136 patients with primary osteoarthritis who were treated between January 2022 and June 2023. Patients were classified according to the type of rehabilitation program: high range of motion (HROM) group or control group. In the HROM group, patients underwent high-intensity rehabilitation, especially without restricting the range of motion (ROM) following knee surgery. In the control group, patients received routine rehabilitation, with the affected knee achieving approximately 90 degrees of flexion at discharge. Patients' data related to postoperative knee ROM, Hospital for Special Surgery (HSS) score, visual analogue scale (VAS) score, transfusion rate, wound complications, thrombus of lower limb, and usage of analgesic drugs were recorded to assess the influence of ROM at discharge on clinical outcomes. The HROM group had a higher knee ROM compared to the control group at discharge (P < 0.001). There were no significant differences between the HROM group and the control group in the basic demographic information, hospital stay and operation time (P > 0.05). HSS scores and knee ROM in the HROM group were significantly higher than those in the control group 1 and 2 months after surgery (P < 0.001). There were no significant differences in VAS at 1, 2 and 7 days after surgery between the two groups. The usage of analgesic drugs, wound complications, thrombus of lower limb, and transfusion rates were similar between the two groups (P > 0.05). High knee ROM at discharge achieved through high-intensity rehabilitation is an effective and simple way to improve early knee mobility and function. The routine application of this protocol did not increase the incidence of wound complications.
- Open Access
- 15 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
The comparative efficacy of L-glutamine, celecoxib, and glucosamine sulfate in osteoarthritis management
To explore the therapeutic efficacy of L-glutamine (L-Gln) on pathological progression and clinical symptoms of osteoarthritis (OA), and compare with glucosamine sulfate (GS), and celecoxib (CXB). Rats were administered sodium chloride, L-Gln, GS, or CXB via gavage for eight weeks starting from the fifth week after sham operation or Anterior Cruciate Ligament Transection (ACLT) + Medial Meniscectomy (MMx). Then the severity of knee OA in rats was evaluated by serological analysis, histological examination and imaging examination. In addition, patients with mild primary OA were administered L-Gln, GS, or CXB orally for 12 weeks in accordance with the randomization principle. The efficacy end points were the change from baseline to week 24 in the pain and physical function subscale scores of the Western Ontario and McMaster Universities OA Index (WOMAC), and Lequesne score. Treatment with L-Gln alleviated the increased concentration of serum cartilage degradation markers caused by OA in rats. Histological tests showed improvement in knee joint cartilage destruction after treatment. Three-dimensional CT scans and reconstructions revealed a reduction in osteophyte formation and subchondral bone loss. L-glutamine performed as well as or better than glucosamine sulfate and celecoxib in all comparative measures among the three treatment groups. In clinical trials, the WOMAC pain and physical function subscale scores, as well as the Lequesne score, decreased from baseline in all three patient groups during follow-up, with no significant differences observed between the groups. Our research indicates that L-Gln is comparable to GS and CXB in improving the pathological progression and clinical efficacy of OA, which makes it a promising drug for the treatment of osteoarthritis.
- 15 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessThe comparative efficacy of L-glutamine, celecoxib, and glucosamine sulfate in osteoarthritis management
To explore the therapeutic efficacy of L-glutamine (L-Gln) on pathological progression and clinical symptoms of osteoarthritis (OA), and compare with glucosamine sulfate (GS), and celecoxib (CXB). Rats were administered sodium chloride, L-Gln, GS, or CXB via gavage for eight weeks starting from the fifth week after sham operation or Anterior Cruciate Ligament Transection (ACLT) + Medial Meniscectomy (MMx). Then the severity of knee OA in rats was evaluated by serological analysis, histological examination and imaging examination. In addition, patients with mild primary OA were administered L-Gln, GS, or CXB orally for 12 weeks in accordance with the randomization principle. The efficacy end points were the change from baseline to week 24 in the pain and physical function subscale scores of the Western Ontario and McMaster Universities OA Index (WOMAC), and Lequesne score. Treatment with L-Gln alleviated the increased concentration of serum cartilage degradation markers caused by OA in rats. Histological tests showed improvement in knee joint cartilage destruction after treatment. Three-dimensional CT scans and reconstructions revealed a reduction in osteophyte formation and subchondral bone loss. L-glutamine performed as well as or better than glucosamine sulfate and celecoxib in all comparative measures among the three treatment groups. In clinical trials, the WOMAC pain and physical function subscale scores, as well as the Lequesne score, decreased from baseline in all three patient groups during follow-up, with no significant differences observed between the groups. Our research indicates that L-Gln is comparable to GS and CXB in improving the pathological progression and clinical efficacy of OA, which makes it a promising drug for the treatment of osteoarthritis.
- Open Access
- 15 January 2025
- Published by Elsevier in Chemical Engineering Journal
- Vol. 505
An injectable reactive oxygen species-responsive self-assembled hydrogel loaded with L-glutamine targets cartilage repair for treatment of osteoarthritis
- 15 January 2025
- Published by Elsevier in Chemical Engineering Journal
- Vol. 505
Open AccessAn injectable reactive oxygen species-responsive self-assembled hydrogel loaded with L-glutamine targets cartilage repair for treatment of osteoarthritis
- Open Access
- 30 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-18
Biocompatible ionized air alleviates rat osteoarthritis by modulating polarization from M1 to M2 macrophages
The imbalance in the proportion of M1/M2 macrophage polarization is a crucial contributor to the persistent progression of osteoarthritis (OA). This study aimed to evaluate the effects of low-dose biocompatible ionized air (BIA) on macrophage polarization and its subsequent chondroprotective effects, thereby validating the potential of BIA in slowing the progression of OA. In vitro experiments demonstrated that BIA modulates the polarization of M1 macrophages toward the M2 phenotype via the ROS-mediated STAT6 pathway. This shift reduces the expression of pro-inflammatory mediators while increasing the expression of anti-inflammatory mediators and pro-chondrogenic factors, leading to an improved microenvironment surrounding chondrocytes. The direct benefits of this improved microenvironment include enhanced chondrocyte viability, inhibition of apoptosis, and reduced degradation of the extracellular matrix. In vivo studies in rats showed that BIA inhibited M1 macrophage infiltration in the synovium, upregulated the proportion of M2 macrophages, alleviated cartilage degeneration, and delayed OA progression. This gas-based regulatory strategy may open new avenues for the treatment of OA.
- 30 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-18
Open AccessBiocompatible ionized air alleviates rat osteoarthritis by modulating polarization from M1 to M2 macrophages
The imbalance in the proportion of M1/M2 macrophage polarization is a crucial contributor to the persistent progression of osteoarthritis (OA). This study aimed to evaluate the effects of low-dose biocompatible ionized air (BIA) on macrophage polarization and its subsequent chondroprotective effects, thereby validating the potential of BIA in slowing the progression of OA. In vitro experiments demonstrated that BIA modulates the polarization of M1 macrophages toward the M2 phenotype via the ROS-mediated STAT6 pathway. This shift reduces the expression of pro-inflammatory mediators while increasing the expression of anti-inflammatory mediators and pro-chondrogenic factors, leading to an improved microenvironment surrounding chondrocytes. The direct benefits of this improved microenvironment include enhanced chondrocyte viability, inhibition of apoptosis, and reduced degradation of the extracellular matrix. In vivo studies in rats showed that BIA inhibited M1 macrophage infiltration in the synovium, upregulated the proportion of M2 macrophages, alleviated cartilage degeneration, and delayed OA progression. This gas-based regulatory strategy may open new avenues for the treatment of OA.
- 1 June 2024
- Published by SAGE Publications in Tissue Engineering Part C: Methods
- Vol. 30 (6) , 268-278
A Biocompatible Nanofibers Modified by Plasma for Osteoblast Growth Differentiation
This work employs nitrogen plasma immersion ion implantation (PIII) to modify electrospinning polylactic acid membranes and immobilizes essential fibroblast growth factors(bFGF) by forming cross-linking bonds. The study investigates the modified membranes' surface characteristics and the stimulatory effects of cross-linked bFGF polylactic acid membranes on osteoblast and fibroblast proliferation. The PIII process occurs under low vacuum conditions and is controlled by processing time and power pulse width. The experimental results indicate that, within a 400-second N2-PIII treatment, the spun fibers remain undamaged, demonstrating an increase in hydrophilicity (from 117° to 38°/36°) and nitrogen content (from 0% to 7.54%/8.05%). XPS analysis suggests the formation of a C-N-C=O cross-linked bond. Cell culture and activity assessments indicate that the PIII-treated and cross-linked bFGF film exhibits significantly higher cell growth activity (P<0.05) than the untreated group. These intergroup differences are attributed to the surface cross-linking bond content. In osteogenic induction, the results for each day show that the treated group performs better. However, the intergroup disparities within the cross-linked bFGF group disappear with prolonged culture time due to the rapid osteogenesis prompted by bFGF. The findings suggest that PIII treatment of electrospinning polylactic acid membranes holds promise in promoting osteogenesis in bone tissue scaffolds.
- 1 June 2024
- Published by SAGE Publications in Tissue Engineering Part C: Methods
- Vol. 30 (6) , 268-278
A Biocompatible Nanofibers Modified by Plasma for Osteoblast Growth Differentiation
This work employs nitrogen plasma immersion ion implantation (PIII) to modify electrospinning polylactic acid membranes and immobilizes essential fibroblast growth factors(bFGF) by forming cross-linking bonds. The study investigates the modified membranes' surface characteristics and the stimulatory effects of cross-linked bFGF polylactic acid membranes on osteoblast and fibroblast proliferation. The PIII process occurs under low vacuum conditions and is controlled by processing time and power pulse width. The experimental results indicate that, within a 400-second N2-PIII treatment, the spun fibers remain undamaged, demonstrating an increase in hydrophilicity (from 117° to 38°/36°) and nitrogen content (from 0% to 7.54%/8.05%). XPS analysis suggests the formation of a C-N-C=O cross-linked bond. Cell culture and activity assessments indicate that the PIII-treated and cross-linked bFGF film exhibits significantly higher cell growth activity (P<0.05) than the untreated group. These intergroup differences are attributed to the surface cross-linking bond content. In osteogenic induction, the results for each day show that the treated group performs better. However, the intergroup disparities within the cross-linked bFGF group disappear with prolonged culture time due to the rapid osteogenesis prompted by bFGF. The findings suggest that PIII treatment of electrospinning polylactic acid membranes holds promise in promoting osteogenesis in bone tissue scaffolds.
- Open Access
- 11 March 2024
- Published by Springer Nature in Research Square
The Efficacy of L-glutamine in Osteoarthritis:a comparative analysis with celecoxib and glucosamine sulfate.
Objective: to explore the therapeutic efficacy of L-glutamine (L-Gln) in osteoarthritis(OA), and compare with glucosamine sulfate (GS), and celecoxib (CXB). Methods: Male SD rats were administered sodium chloride, L-Gln, GS, or CXB via gavage for eight weeks starting in the fifth week after operation. Then the severity of knee OA in rats was evaluated by serological analysis, histological examination and imaging examination. Patients with mild OA were administered L-Gln, GS, or CXB orally for 12 weeks in accordance with the randomization principle. Efficacy end points were the change from baseline to week 24 in the pain and physical function subscale scores of the Western Ontario and McMaster Universities OA Index (WOMAC), and Lequesne score. Results: The treatment with L-Gln and two other drugs alleviated the increased concentration of serum cartilage degradation markers, cartilage destruction, osteophyte formation, and loss of subchondral bone mass caused by OA in rats. During follow-up, the WOMAC pain and physical function subscale scores and Lequesne score of all three groups of patients decreased from baseline and exceeded the minimum clinical difference. The results indicate that the therapeutic effect of L-Gln is comparable to the other two drugs, and in some indicators, it may even be superior to them. Conclusion: Our research indicates that L-Gln is comparable to GS and CXB in improving the pathological progression and clinical efficacy of OA. However, L-Gln has a lower occurrence of gastrointestinal adverse reactions and effectively alleviates knee joint pain in OA patients who are unresponsive to NSAIDs and GS. This makes it a promising drug for the treatment of osteoarthritis.
- 11 March 2024
- Published by Springer Nature in Research Square
Open AccessThe Efficacy of L-glutamine in Osteoarthritis:a comparative analysis with celecoxib and glucosamine sulfate.
Objective: to explore the therapeutic efficacy of L-glutamine (L-Gln) in osteoarthritis(OA), and compare with glucosamine sulfate (GS), and celecoxib (CXB). Methods: Male SD rats were administered sodium chloride, L-Gln, GS, or CXB via gavage for eight weeks starting in the fifth week after operation. Then the severity of knee OA in rats was evaluated by serological analysis, histological examination and imaging examination. Patients with mild OA were administered L-Gln, GS, or CXB orally for 12 weeks in accordance with the randomization principle. Efficacy end points were the change from baseline to week 24 in the pain and physical function subscale scores of the Western Ontario and McMaster Universities OA Index (WOMAC), and Lequesne score. Results: The treatment with L-Gln and two other drugs alleviated the increased concentration of serum cartilage degradation markers, cartilage destruction, osteophyte formation, and loss of subchondral bone mass caused by OA in rats. During follow-up, the WOMAC pain and physical function subscale scores and Lequesne score of all three groups of patients decreased from baseline and exceeded the minimum clinical difference. The results indicate that the therapeutic effect of L-Gln is comparable to the other two drugs, and in some indicators, it may even be superior to them. Conclusion: Our research indicates that L-Gln is comparable to GS and CXB in improving the pathological progression and clinical efficacy of OA. However, L-Gln has a lower occurrence of gastrointestinal adverse reactions and effectively alleviates knee joint pain in OA patients who are unresponsive to NSAIDs and GS. This makes it a promising drug for the treatment of osteoarthritis.